In the era of evidence-based practice, we need practice-based evidence. The basis of this evidence is the detailed information from the case reports of individual people which informs both our clinical research and our daily clinical care. Each case report published in this journal adds valuable new information to our medical knowledge.
Prof Michael Kidd AM, Editor-in-Chief
Join the Editorial Board
We are recruiting Associate Editors to join our Editorial Board. Learn more about the role and how to apply here!
Meet the Editors
Get to know the Editors behind Journal of Medical Case Reports!
megaflopp / Getty Images / iStock
Requirements for case reports submitted to JMCR
• Patient ethnicity must be included in the Abstract under the Case Presentation section.
• Consent for publication is a mandatory journal requirement for all case reports. Written informed consent for publication must be obtained from the patient (or their parent or legal guardian in the case of children under 18, or from the next of kin if the patient has died). For more information, please see our editorial policies.
Report of the Month
Concomitant myocarditis and painless thyroiditis after AstraZeneca coronavirus disease 2019 vaccination
Since the emergence of the COVID-19/SARS-CoV-2 pandemic, effective vaccines against COVID-19 have been developed. The AstraZeneca COVID-19 vaccine, a replication-deficient adenoviral vector vaccine that contains the SARS-CoV-2 spike protein gene, triggers the immune system to generate an immune response against the coronavirus and retain that information in memory immune cells. The most well-publicized adverse reactions are vaccine-induced thrombosis and thrombocytopenia.
In this article, clinicians report the case of a patient who developed concomitant myocarditis and painless thyroiditis after receiving the AstraZeneca COVID-19 vaccine.
Articles
-
-
Fibroadenoma in axillary accessory breast tissue: a case report
-
Fungal keratitis caused by Scedosporium apiospermum: a case report
-
Solar maculopathy secondary to sunlight exposure reflected from the screen of mobile devices: two case reports
-
Drug rash with eosinophilia and systemic symptoms syndrome masquerading as a lymphoproliferative disorder in a young adult on immunosuppressive therapy for rheumatoid arthritis: a case report
-
An itchy erythematous papular skin rash as a possible early sign of COVID-19: a case report
-
Red ear syndrome precipitated by a dietary trigger: a case report
-
COVID-19 with repeated positive test results for SARS-CoV-2 by PCR and then negative test results twice during intensive care: a case report
-
Recurrent knee arthritis diagnosed as juvenile idiopathic arthritis with a 10-year asymptomatic period after arthroscopic synovectomy: a case report
-
How to choose the best journal for your case report
The Erratum to this article has been published in Journal of Medical Case Reports 2017 11:287
A Guide to Writing and Using Case Reports
This thematic series, published in 2016, provides a valuable resource for clinicians who are considered producing a case report. It comprises of a special editorial series of guides on writing, reviewing and using case reports.
Developed by the CARE Group in 2013, the CARE guidelines provide a framework that supports transparency and accuracy in the publication of case reports and the reporting of information from patient encounters.
Aims and scope
Journal of Medical Case Reports will consider any original case report that expands the field of general medical knowledge, and original research relating to case reports.
Case reports should show one of the following:
- Unreported or unusual side effects or adverse interactions involving medications
- Unexpected or unusual presentations of a disease
- New associations or variations in disease processes
- Presentations, diagnoses and/or management of new and emerging diseases
- An unexpected association between diseases or symptoms
- An unexpected event in the course of observing or treating a patient
- Findings that shed new light on the possible pathogenesis of a disease or an adverse effect
Suitable research articles include but are not limited to: N of 1 trials, meta-analyses of published case reports, research addressing the use of case reports and the prevalence or importance of case reporting in the medical literature and retrospective studies that include case-specific information (age, sex and ethnicity) for all patients.
Article accesses
Throughout 2021, articles were accessed from the journal website more than 4.33 million times; an average of over 11,800 accesses per day.
Latest Tweets
View Twitter timeline
Your browser needs to have JavaScript enabled to view this timeline
Peer Review Mentoring Scheme
The Editors at Journal of Medical Case Reports endorse peer review mentoring of early career researchers.
If you are a senior researcher or professor and supervise an early career researcher with the appropriate expertise, we invite you to co-write and mentor them through the peer review process. Find out how to express your interest in the scheme here.
About the Editor-in-Chief
Professor Michael Kidd AM FAHMS is Professor of Primary Care Reform at the Australian National University, and Principal Medical Advisor to the Australian Government Department of Health. He is Adjunct Professor with the Department of Family and Community Medicine at the University of Toronto, Honorary Professor of Global Primary Care with the Southgate Institute for Health, Equity and Society at Flinders University, Professorial Fellow with the Murdoch Children's Research Institute at the Royal Children’s Hospital in Melbourne, and Emeritus Director of the World Health Organization Collaborating Centre on Family Medicine and Primary Care. He served as president of the World Organization of Family Doctors (WONCA) from 2013-2016, and as president of the Royal Australian College of General Practitioners from 2002-2006. He is the founder and Editor-in-Chief of the Journal of Medical Case Reports, the world's first PubMed-listed journal devoted to publishing case reports from all medical disciplines.
Annual Journal Metrics
-
Citation Impact
0.757 - Source Normalized Impact per Paper (SNIP)
0.287 - SCImago Journal Rank (SJR)
1.300 - CiteScoreSpeed
103 days to first decision for all manuscripts (Median)
103 days to first decision for reviewed manuscripts only (Median)Usage
4,322,849 Downloads (2021)
3,006 Altmetric mentions (2021)